Pretty hard to reject a drug that safety is not ev
Post# of 5066
Posted On: 06/21/2013 1:28:35 PM
Pretty hard to reject a drug that safety is not even an issue... only effiacy 
Thats why ive been reading through biology, chemistry, and biochem the last tad. These technologies are incredible and im not a "degree registered academic scientist" but I do consider myself many titles which arent government recognized.
Get a microbiology pdf, type in keywords, look up key cell, inhibitor, molocule, etc etc in the pdf... learning goes faaaast.
Whatever terms you dont know from translational medicine article can be found... maybe ill write a "lamence terms" article about it.
Im not worried about the drug failing, just bmsn finances tbh. Once the news hits saying "bmsn is starting trials, approval granted" I will be dancing.... smoke a cigar, maybe have an e-toast with you fellows with champagne
But... til then...
Thats why ive been reading through biology, chemistry, and biochem the last tad. These technologies are incredible and im not a "degree registered academic scientist" but I do consider myself many titles which arent government recognized.
Get a microbiology pdf, type in keywords, look up key cell, inhibitor, molocule, etc etc in the pdf... learning goes faaaast.
Whatever terms you dont know from translational medicine article can be found... maybe ill write a "lamence terms" article about it.
Im not worried about the drug failing, just bmsn finances tbh. Once the news hits saying "bmsn is starting trials, approval granted" I will be dancing.... smoke a cigar, maybe have an e-toast with you fellows with champagne
But... til then...
(0)
(0)RIVULET MEDIA INC. (RIVU) Stock Research Links
Scroll down for more posts ▼